Abstract CT268: Targeting replication stress and chemotherapy resistance with a combination of sacituzumab govitecan and berzosertib: A phase I clinical trial

Abel, Melissa L., Takahashi, Nobukyuki, Desai, Parth · Cancer Research · 2023